Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma
Hosted on MSN
5h
How Ketamine Therapy Helps With Depression And PTSD
Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
Association for Psychological Science
9d
Treatment Could Provide Relief for Comorbid Depression and Anxiety
For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
10d
Inside an experimental program treating depression and anxiety
The Inspired Performance Program is a new mental health treatment that aims to resolve how your body responds to years of ...
3d
J&J's Spravato Wins FDA Approval, Stands as a Game-Changer for Mental Health Care
New Brunswick, NJ January 21, 2025 Johnson & Johnson ( NYSE:JNJ) has finally got its breakthrough depression treatment, ...
2d
on MSN
Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
8h
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Governing
17h
How Baltimore Convinced Officers to Seek Help for Alcoholism and Depression
The city’s police department has put a focus on officer mental health and well-being. That’s a big cultural change because ...
6d
on MSN
Insurance barriers restrict patients’ access to mental health treatment
THIRUVANANTHAPURAM: Insurance companies are increasingly using patients’ mental health treatment records to deny them claims ...
News24
1d
Mental health and motherhood: South Africa now has treatment guidelines, the trick will be to make them work
South Africa's new maternity care guidelines address a critical gap by recognising maternal mental health, yet implementation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback